214272-33-0
Chemical Structure
RGH-1875 hydriodide
Synonym(s): GYKI 39521 hydriodide
- CAS No.: 214272-33-0
- Formula:C13H18INO3S3
- Molecular Weight:459.39
IUPAC Name: methyl 4-(((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-thiopyran-2-yl)thio)benzimidothioate hydroiodide
InChIKey: QTGHPZDEIBRYFG-JCTRTAIQSA-N
SMILES: CSC(C(C=C1)=CC=C1S[C@H]2[C@@H]([C@H]([C@H](O)CS2)O)O)=N.I
Biological Activity: RGH-1875 (GYKI 39521) hydriodide is the hydriodide of RGH-1875. RGH-1875 is an orally active antithrombotic agent. RGH-1875 prevents endotoxin-induced decreases in fibrinogen level and platelet count, reduces the level of fibrin degradation products and inhibits the endotoxin-induced enhancement of fibrinolytic activity in a rabbit model of endotoxin-induced disseminated intravascular coagulation. RGH-1875 can be used for the study of thrombotic diseases[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
RGH-1875 hydriodide | RGH-1875 (GYKI 39521) hydriodide is the hydriodide of RGH-1875. RGH-1875 is an orally active antithrombotic agent. RGH-1875 prevents endotoxin-induced decreases in fibrinogen level and platelet count, reduces the level of fibrin degradation products and inhibits the endotoxin-induced enhancement of fibrinolytic activity in a rabbit model of endotoxin-induced disseminated intravascular coagulation. RGH-1875 can be used for the study of thrombotic diseases. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
